Delivery Order SPE2DB24D2101-SPE2DB25FKNNE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units) with a ceiling value of $9,867.80 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $22,005.93 to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Fingolimod is a disease-modifying therapy used in the treatment of...
- The Defense Logistics Agency awarded a $5,394.00 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count packages). This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The award was made on a firm fixed-price basis with no set-aside designation,...
- The Defense Logistics Agency awarded a $10,360.75 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fingolimod 0.5 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,811.90, is for the delivery of Fingolimod 0.5 mg capsules. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,047.16 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of fingolimod 0.5 mg capsules and has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that Amerisourcebergen holds with DLA Troop Support Medical for...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain neurological conditions. The contract has a ceiling value of $16,009.46 and a performance period ending on June 24, 2025. This award is not designated as a set-aside contract, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules. The contract has a firm fixed price of $13,261.27 and an ultimate completion date of August 5, 2024. It is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, is for the delivery of fingolimod 0.5 mg capsules. The contract is a firm fixed price delivery order with a ceiling value of $94,359.55 and a period of performance through March 27, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this award. The company is a subsidiary of Amerisourcebergen Corporation, a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a neurological medication, with a ceiling value of $28,649.02. The contract is a firm fixed-price delivery order, with a performance period ending on May 6, 2025. This contract is not designated as a set-aside and was likely competed openly. AmerisourceBergen Drug Corp holds a...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNNEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fingolimod 0.5 mg capsules (30-count units) with a ceiling value of $1,497.86. This competitive, non-set-aside award was executed on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizing firm fixed-price pricing. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current delivery order for Fingolimod—a neurological treatment medication—reflects AmerisourceBergen's role as a critical vendor within the Defense Health Agency's medical supply chain and demonstrates the company's capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains on an accelerated timeline.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/19/25 |